LLY

785.76

-1.21%↓

JNJ

152.76

+0.26%↑

ABBV

186.41

-0.43%↓

NVO

68.78

+2.32%↑

UNH

307.81

+1.17%↑

LLY

785.76

-1.21%↓

JNJ

152.76

+0.26%↑

ABBV

186.41

-0.43%↓

NVO

68.78

+2.32%↑

UNH

307.81

+1.17%↑

LLY

785.76

-1.21%↓

JNJ

152.76

+0.26%↑

ABBV

186.41

-0.43%↓

NVO

68.78

+2.32%↑

UNH

307.81

+1.17%↑

LLY

785.76

-1.21%↓

JNJ

152.76

+0.26%↑

ABBV

186.41

-0.43%↓

NVO

68.78

+2.32%↑

UNH

307.81

+1.17%↑

LLY

785.76

-1.21%↓

JNJ

152.76

+0.26%↑

ABBV

186.41

-0.43%↓

NVO

68.78

+2.32%↑

UNH

307.81

+1.17%↑

Search

BeOne Medicines Ltd ADR

Open

SectorHealthcare

242.64 -6.27

Overview

Share price change

24h

Current

Min

232.55

Max

259.1

Key metrics

By Trading Economics

Income

153M

1.3M

Sales

-11M

1.1B

Profit margin

0.114

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+31.16% upside

Dividends

By Dow Jones

Next Earnings

6 sie 2025

Market Stats

By TradingEconomics

Market Cap

22B

Previous open

248.91

Previous close

242.64

News Sentiment

By Acuity

50%

50%

154 / 380 Ranking in Healthcare

BeOne Medicines Ltd ADR Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

12 maj 2025, 02:16 UTC

Major Market Movers

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

29 sty 2025, 15:59 UTC

Major Market Movers

ImmunityBio Shares Rise After Collaboration, Supply Agreement With BeiGene

27 lis 2024, 15:22 UTC

Major Market Movers

BeiGene Shares Up on EU Approval for Gastric, Esophageal Cancer Treatment

21 lis 2024, 14:45 UTC

Major Market Movers

Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK

22 paź 2024, 18:39 UTC

Major Market Movers

Indaptus Therapeutics Shares Rise After Pact to Develop Cancer Treatment

7 maj 2025, 10:07 UTC

Earnings

BeiGene Maintains 2025 Expense Guidance of $4.1B to $4.4B >ONC

7 maj 2025, 10:06 UTC

Earnings

BeiGene Backs 2025 Rev $4.9B-$5.3B >ONC

7 maj 2025, 10:05 UTC

Earnings

BeiGene 1Q Net $1.27M >ONC

7 maj 2025, 10:04 UTC

Earnings

BeiGene Says to Rename Company to BeOne Medicines >ONC

7 maj 2025, 10:02 UTC

Earnings

BeiGene 1Q EPS $0.00 >ONC

7 maj 2025, 10:02 UTC

Earnings

BeiGene 1Q Rev Increased 49% >ONC

7 maj 2025, 10:00 UTC

Earnings

BeiGene 1Q Rev $1.12B >ONC

27 lut 2025, 11:07 UTC

Earnings

BeiGene Sees 2025 Rev $4.9B-$5.3B >ONC

27 lut 2025, 11:06 UTC

Earnings

BeiGene 4Q Global BRUKINSA Rev of $828M >ONC

27 lut 2025, 11:06 UTC

Earnings

BeiGene 4Q Loss/Shr 11c >ONC

27 lut 2025, 11:06 UTC

Earnings

BeiGene 4Q Rev $1.13B >ONC

12 lis 2024, 11:01 UTC

Earnings

BeiGene 3Q Loss/Shr 9c >BGNE

12 lis 2024, 11:01 UTC

Earnings

BeiGene 3Q Rev $1B >BGNE

7 sie 2024, 10:05 UTC

Earnings

BeiGene 2Q Loss/Shr $1.15 >BGNE

7 sie 2024, 10:04 UTC

Earnings

BeiGene 2Q Rev $929M >BGNE

Peer Comparison

Price change

BeOne Medicines Ltd ADR Forecast

Price Target

By TipRanks

31.16% upside

12 Months Forecast

Average 333.78 USD  31.16%

High 359.47 USD

Low 300 USD

Based on 8 Wall Street analysts offering 12 month price targets forBeOne Medicines Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

7

Buy

1

Hold

0

Sell

Sentiment

By Acuity

154 / 380 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Operating profit

$

About BeOne Medicines Ltd ADR

BeiGene Ltd